17
Mar
Mar
SK Group, one of South Korea’s massive, family-controlled businesses known as chaebol, is expected to list its vaccine making unit, SK Bioscience, this week on the Korea Stock Exchange. SK Bioscience, which produces Covid-19 vaccines in Korea, could raise up to $1.33 billion, which would be the biggest Korea IPO since 2017. “We have strengthened our leadership […]